Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Recruiting · NCT06156410 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas | Disease Attributes, Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 1 | 2026-09-03 | NCT06156410 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alex's Lemonade Stand Foundation | 6 |
| Children's Hospital Colorado | 46 |
| Children's Hospital of Philadelphia | 215 |
| Exelixis | 77 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital Colorado | Aurora | United States | 312 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| University of California San Francisco | San Francisco | United States | 144 |
| University of Pennsylvania | Philadelphia | United States | 507 |